Acetaminophen/Propyphenazone/Caffeine

对乙酰氨基酚/异丙安替比林/咖啡因

Report date: 2022/03/09 09:37:02

Base Information

Drug NameAcetaminophen/Propyphenazone/Caffeine
Drug Alias Name复方对乙酰氨基酚片散利痛散列通
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitorsAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsCyclooxygenasesAdenosine A1 receptorAdenosine A2a receptor
Therapy Area/IndicationsCommon Cold
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AcetaminophenPropyphenazoneCaffeine
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCommon Cold
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A